Search results for: Central and Eastern Europe
Filter search results
Health Financing and Pharmaceutical Policy Reform in the Countries of Central and Eastern Europe
12 January 1997
…care sector in the Countries of Central and Eastern Europe (CCEE). It shall assess the overall direction of the reforms and focus in particular on health financing and pharmaceutical policy…
Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?
12 April 2024
…European Commission and EFPIA proposals. [online] Available at: https://www.efpia.eu/media/msadqxbf/revision-of-the-general-pharmaceutical-legislation-gpl-impact-assessment.pdf [Accessed 5 Apr. 2024]. Dubois, P., de Mouzon, O., Scott-Morton, F. and Seabright, P., 2015. Market size and pharmaceutical innovation. The RAND Journal…
Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
1 December 2017
…in terms of adoption decisions and access across England, Scotland and Wales. The centralised procedure was created in 1995 to facilitate access to innovative medicines across the European Union. Since…
Altering the trajectory of HIV in Europe
22 May 2025
…language, and are targeted at both general populations and healthcare professionals, have the potential to educate and reduce prejudice and stigma. Diversifying treatment options: PrEP and antiretroviral therapy (ART) are…
Routine Funding in the UK NHS of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
18 December 2017
…to innovative medicines across the European Union (EU). Since then the scope of authorisation via the centralised procedure has been broadened and made mandatory for orphan and oncology medicines. We…
Achieving Accelerated Patient Access to Cancer Care in Europe
3 November 2025
…key principles and processes that can be applied at a national and pan-European level. The framework covered four key phases: eligibility criteria, initial assessment, reassessment, and exit criteria. Within these…
Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics
16 January 2024
…options 1 and 2 and seems to indicate that they are plausible pathways (European Commission, European Health and Digital Executive Agency, 2023). Elsewhere, member states have suggested the Health Emergency Preparedness and Response…
An eye on sustainability at the Economist’s Future of Health Europe
30 October 2023
…requires inter-productivity, communication, and education to ensure effective and equitable implementation and adoption. Istvan Ujhelyi (European Parliament) shared that the lack of coordination across member states hinders the development and…
Reflections from Glasgow
11 November 2025
…Health (DHSC) and NICE. These were included in the 2009PPRS and maintained and enhanced in each subsequent 5-year pricing agreement between the industryand the UK government, including the recent 2023…